News & Press Releases

Sera Prognostics Completes $100 Million Series E Financing

April 28, 2021-Several prominent healthcare-focused institutional investors fund Sera to expand commercialization of the PreTRM® Test. MORE >

Sera Prognostics Appoints Benjamin G. Jackson as General Counsel

April 13, 2021-Highly accomplished attorney joins Sera to develop its legal and intellectual property functions. MORE >

SERA PROGNOSTICS APPOINTS ROBERT G. HARRISON AS CHIEF INFORMATION OFFICER

March 31, 2021- Accomplished technology leader joins Sera to build and deploy its information strategy. MORE >

AMERICAN MEDICAL ASSOCIATION (AMA) GRANTS SERA PROGNOSTICS A CPT® PLA CODE FOR PreTRM®, THE ONLY BROADLY VALIDATED BLOOD TEST TO ASSESS RISK OF PRETERM BIRTH

February 3, 2021- Receipt of dedicated CPT® code marks important commercialization milestone to pursue reimbursement for the PreTRM® Test. MORE >

Sera Prognostics Partners With Anthem and HealthCore to Improve Outcomes for Preterm Babies

January 05, 2021- Patient enrollment began in November for this rigorous prospective, randomized, controlled PRIME intervention trial to demonstrate the value of implementing the PreTRM® prevention strategy to improve neonatal outcomes and lower cost of care. MORE >

Sera Prognostics to Present at Baird’s 2020 Global Health Care Conference

September 9, 2020- Sera will be presenting at the upcoming Baird 2020 Global Health Care Conference. A virtual conference, Sera’s presentation will take place on Thursday, September 10 at 10:50 a.m. ET. MORE >

Sera Prognostics Appoints Thomas J. Garite, M.D. as Vice President of Clinical Sciences

June 24, 2020 - Sera announced the appointment Thomas J. Garite, M.D. as Vice President of Clinical Sciences. - Dr. Garite will support clinical development and operations as Sera transitions from clinical to commercial-stage company. MORE >

Publication Demonstrates Ability of Sera Prognostics’ PreTRM® Biomarker Test as a Predictor of Adverse Pregnancy Outcomes

May 20, 2020 - Sera Prognostics, Inc., The Pregnancy Company® announced the publication of positive data in a large, independent, contemporary prospective U.S. clinical cohort study, TREETOP (NCT02787213), in the American Journal of Obstetrics & Gynecology Maternal Fetal Medicine. MORE >

Sera Prognostics Appoints Jay M. Moyes as Chief Financial Officer

April 2, 2020 - Sera announced the appointment of Jay M. Moyes as Chief Financial Officer. MORE >

Sera Prognostics to Present at the 40th Annual Cowen Health Care Conference

Feb 24, 2020 -- Sera will be presenting at the upcoming Cowen 2020 Health Care Conference at the Boston Marriott Copley Place in Boston on Tuesday, March 3rd, at 11:30 a.m. ET. MORE >